As we all continue to live through these very difficult times, our main priority is the safety and wellbeing of our staff, their families and the community. As an essential facility in the development of new medicines, we remain fully operational. We are following government guidelines and are keeping all our clients updated as the [...]
The meeting that ApconiX is co-organising the British Toxicology Society “Science-led Strategies for Success in Discovery and Development Toxicology” is being rearranged for a date later in 2020 - watch this space for updates! Sponsored by Lonza and AstraZeneca and co-organised by ApconiX, GlaxoSmithKline, Sygnature Discovery and Alderley Park, the meeting is focused on safety [...]
Phumzile Sikakana talks about ApconiX’s fundraising for 2019 and looks forward to 2020. “ApconiX have had an absolutely fantastic 6 months of fundraising for Macmillan Cancer Support. Our grand total is an amazing £2000! I'd personally like to say a massive thank you to everyone that has supported us, and I hope you’ve had as [...]
Team ApconiX had a fabulous time at their Christmas party - secret Santa brought tears of laughter and sorrow and the odd gasp! A few team members went incognito. Wishing everyone a lovely holiday and the very best for the coming year. Looking forward to a new decade and new challenges. See you in 2020!
Dr Michael Morton is attending “Accelerating Biopharma R&D with Innovative Biopharma Data Management and Analysis” at the Swiss Embassy in London today. The event was organised by Genedata. Speakers include Dr Peter Whitfield, Senior Scientific Data Analyst at GSK, Chris Wilson, Senior Scientist at Crescendo Biologics Limited, Alex Stowell, Lead Biologist at CRUK Manchester Institute [...]
ApconiX would like to congratulate Andrew Walker from BioScript for correctly guessing the number of sweets in the jar. There were 199 in total, lucky Andy gets to walk away with all that delicious Lindt chocolate! We have now raised over a £1000 since the summer for our charity of the year, Macmillan Cancer Support. [...]
ApconiX is delighted to be presenting a poster at ELRIG 2019 titled “Sodium channel selectivity of two anti-epileptic drugs.” The poster includes research started by our placement student Priscilla Dumenu. Dr Michael Morton, Dr Richard Knight, Dr Kimberly Rockley, Phumzile Sikakana and Olivia Turner are all attending the conference. “I am really looking forward to [...]
Professor Ruth Roberts, Co-Founder and Director of ApconiX will be speaking at the American Association of Pharmaceutical Scientists (AAPS) on Monday 4th November at 9:00am in a session entitled "Next Generation Technologies in Preclinical Development” chaired by Dr Shraddha Thakkar from the US FDA. Ruth’s talk is entitled “Science-Driven Design of the Preclinical Package: Case [...]
Phumzile Sikakana talks about the final part of her Triple Half Marathon Challenge. “I took to the streets of south Manchester on Sunday the 13th of October to complete my final half marathon, making it 3 races in 6 weeks. Honestly, I had let my training slip since the start of the challenge, so I [...]
Dr Michael Morton, Director and Co-Founder will be speaking at the 10th Nanion User Meeting on Thursday 17th of October, "Two Years of Experience and Learning with Patchliner". The User Meeting is being held from Wednesday 17th to Thursday 18th of October at Nanion’s headquarters in Munich. Founded in 2002, Nanion has grown to be [...]
